Jim Cramer Shares Big Advantage For CVS Health Corporation (CVS)

We recently published Jim Cramer Said Allbirds Management Are “Jokers” & Discussed These 18 Stocks. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer.

CVS Health Corporation (NYSE:CVS) is a diversified healthcare company with a presence in the insurance, pharmacy, and other sectors. Its shares are up by 9% over the past year and are down by 6% year-to-date. UBS discussed CVS Health Corporation (NYSE:CVS)’s stock on March 25th as it reiterated a Buy rating and a $97 share price target. The firm’s settlement with the FTC for insulin pricing was on UBS’ mind as it opined that the resolution could generate tailwinds for the shares. The settlement was also on Leernik’s radar as it maintained an Outperform rating and a $98 share price target for CVS Health Corporation (NYSE:CVS)’s shares. The firm also pointed towards the healthcare company’s PBM business being a major beneficiary of the settlement. Earlier this month, the Trump administration increased Medicare Advantage payments, and as he discussed the increase with his co-host, Cramer also commented on CVS Health Corporation (NYSE:CVS):

“I like CVS. Because I’ve got to tell you, that company is a survivor of Rite Aid and Walgreens. And they’re doing a lot of great things. David Joiner, have you spoken to him? Hitter. This guy’s a hitter. And he’s making it so that CVS is going to be America’s drug store.”

Viking Therapeutics (VKTX) Stock Has Failed To Impress Since Jim Cramer Expressed Caution

Pixabay/Public Domain

While we acknowledge the risk and potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CVS and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.